by David Eyre | May 25, 2023 | EPO
In laboratory practice the production of new antibodies is now often considered routine with a desired epitope synthesised and used to raise antibodies to that specific sequence. Accordingly under European practice the EPO views generating antibodies against any known...
by Alex Bajjon | Apr 4, 2023 | EPO
Under the current versions of Rules 126 and 127 EPC, communications/documents are deemed to have been notified to the recipient on the tenth day following the date of the document (regardless of how they are transmitted – electronically or by postal services). Many...
by George Schlich | Mar 24, 2023 | EPO
The guidance is: in support of inventive step, yes, post-filed data can be used, if it relates to the same invention as disclosed in the original application. Summary of the Decision In summary, in support of inventive step in a claim in a European patent: • yes,...
by Juliette Boynton | Mar 22, 2023 | EPO
As we know, when claiming priority from an earlier application, one of the tests for a valid priority claim is that it relates to the “same invention”; this being essentially the same as the test for added matter and requiring a “direct and unambiguous” disclosure of...
by Sean Hutchinson | Feb 20, 2023 | EPO, UPC
We reported in our article of December 2022 that the start date of the Unified Patent Court (“UPC”) had been delayed yet again, this time in view of some difficulties many users were having with acquiring the authentication devices required to access the UPC’s Case...
by Eddie Bishop | Feb 3, 2023 | EPO
Background Historically (pre-2019), a subrange was considered novel over the prior art if the following criteria were met (T198/84 and T279/89): a) The selected subrange is narrower than the known range; b) The selected subrange is sufficiently far removed from any...
Recent Comments